Click a topic below for an index of articles:

New Material

Home

Help us Win the Fight!

Alternative Treatments

Depression

Financial or Socio-Economic Issues

Health Insurance

Help us Win the Fight

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Religion and infectious diseases

Our Board

Projects

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us your paper to info@heart-intl.net


 

~

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

 

Prescription Drugs


 

Main topics can be found within the left column; sub-topics and/or research reports can be found near the bottom of this page.  Thank you

 

 

We offer a monthly newsletter dealing with the various issues surrounding infectious diseases.  To find out more click HERE.

"The findings and the drug studies, along with a sharply worded editorial where Dr. Marcia Angell raises the question "Is Academic Medicine For Sale?" appears one week after the Journal's publisher, the Massachusetts Medical Society, announced it would replace her as editor with a prominent asthma researcher who has strong ties to the drug industry.

This report comes at a time when "academic medical centers are no longer the sole citadels of clinical research and the industry is wielding more power in conducting large-scale drug tests. Six of the 12 investigators interviewed cited cases of articles whose publication was stopped or whose content was altered by the funding company. The companies are not identified.

In one instance, a drug maker delayed publication of a study's results by requesting changes to the manuscript to make the product look better. During the delay, the company secretly wrote a competing article on the same topic, which was favorable to the company's viewpoint.

Another investigator found that a drug he was studying caused adverse reactions. He sent his manuscript to the sponsoring company for review. The company vowed never to fund his work again and published a competing article with scant mention of the adverse effects." from Research and Drugs How Investigators are Influenced

Document Name & Link to Document

Description

File Size /Type

Arabian nights: 1001 tales of how pharmaceutical companies cater to the material needs of doctors

Short term outcomes were heterogeneous, underlying the diversity of the means employed by the pharmaceutical industry to subvert, divert, and influence medical practice

 

Are Pharmaceutical co.-addressing stigma

If the public perceived psychiatrists and psychiatric health care providers as caring healers, the stigma around mental illness could be reduced.

Pdf 270 kb

Assessing the Value of America's Investment in Medical Research

 How does a venture capitalist decide where to invest his money? He compares the potential for return against the risk, and when the return appears to be significant and the risk isn't too great, he invests. As our country makes decisions about its future investment in medical research, it might apply a similar standard.

 

Cheap drugs 'not enough to fight AIDS in Africa'

A hard-won battle for access to cheap generic drugs leaves poor African countries ill-prepared to implement nationwide programmes to treat Aids sufferers, experts working on health projects on the continent warn.

 

Drug Middlemen Are Facing Pressure Over Rising Prices

As employers, consumers and government officials grow increasingly frustrated by upwardly spiraling drug costs, pressure is building against a handful of powerful companies that have prospered for years as middlemen between drug manufacturers and those who pay for medicines.

 

Evidence-Based Management of Hepatitis C: A Clinician’s Guide to Pegylated Interferons The hepatitis C story is an ongoing tale of discovery, with the chapters on viral pathogenesis, patient risk stratification, and treatment constantly in need of revision.  This brief symposium review highlights several key areas of current interest in the diagnosis and management of chronic hepatitis C infection 482 kb pdf

Foster City company discounts AIDS drug for poor nations

The pledge by the Foster City biotech firm left unanswered a key detail -- how steeply the company will discount its one-a-day AIDS drug called Viread that wholesales for about $10 a day in the United States.

 

General practitioners and representatives of pharmaceutical companies

Encounters between general practitioners and pharmaceutical representatives follow a consistent format that is implicitly understood by each player. It is naive to suppose that pharmaceutical representatives are passive resources for drug information. General practitioners might benefit from someone who can provide unbiased information about prescribing in a manner that is supportive and sympathetic to the demands of practice

 

How to Enroll in a Drug Study

There are several ways in which patients and their physicians can learn of clinical trials in which they may want to take part.

 

Hungary curbs drug company advertising

Hungary's pharmaceutical manufacturers are facing a clampdown on the methods they use to advertise and market their products to doctors. A health ministry decree, due to become effective within the next few weeks, will drastically limit what has been termed "rampant marketing" by manufacturers

 

Madison Ave. Has Growing Role In the Business of Drug Research

Article on how Madison Avenue, whose television ads have helped turn some prescription drugs into billion-dollar products, is expanding role in drug development;

 

Patients, not Employers or Insurers, Paying Larger Percentage of Prescription Medication Costs

Faced with "rapidly rising" prescription drug spending, which is climbing at about 15% per year, employers and insurers have increasingly shifted the costs to patients, who "may soon pay even more,"

 

Prescription Drug Sales Increased By Nearly 20% Last Year in US

Retail prescription drug spending in the US increased for the fifth straight year in 2000, primarily reflecting higher sales of a relatively small number of drugs.

 

Research and Drugs How Investigators are Influenced

Drug companies that pay for research and clinical tests of new medicines have been suppressing or manipulating the results. The prestigious, peer-reviewed Journal also warned the likelihood that drug test results will be manipulated or suppressed is even greater when for-profit companies set up specifically to test drugs conduct the trials.

 

Tampering With Prescription Drugs?

Some prescription drugs are tampered with as they pass through several middlemen on their way to the local pharmacy, reports 60 Minutes correspondent Bob Simon. What’s more, if the drugs’ manufacturers find out, they are not required to tell patients or the FDA that the drugs could be dangerous.

 

Targets for Anti-Retroviral Treatment

The Mozambican Health Ministry plans to assist over 100,000 HIV-positive people with anti-retroviral drug treatment over the next five years, according to a report in Tuesday's issue of the Maputo daily "Noticias".

 

The Other Drug War Part 1

(LARGE REPORT-INCREASED DOWN-LOAD TIME)

For several decades, the pharmaceutical industry has benefited from a combination of government intervention and laissez faire: the federal government provides stringent intellectual property right protections and generous public subsidies for research-- but does not regulate drug prices. As a result, the United States has been a leader in the development of new drugs, but it also faces the highest drug prices in the world.

 

The Other Drug War Part 2

(LARGE REPORT-INCREASED DOWN-LOAD TIME)

For several decades, the pharmaceutical industry has benefited from a combination of government intervention and laissez faire: the federal government provides stringent intellectual property right protections and generous public subsidies for research-- but does not regulate drug prices. As a result, the United States has been a leader in the development of new drugs, but it also faces the highest drug prices in the world.  

The Other Drug War:
Big Pharma’s 625 Washington Lobbyists

This new Public Citizen report shows how the pharmaceutical industry fought last year, like never before, against the looming threat that Congress and President Clinton would provide senior citizens with drug coverage under Medicare.

PDF 318 kb

Theft, resale of drugs to be curbed

Under the proposal approved by the commission developing countries should be guaranteed access to cut-price HIV/AIDS, TB and malaria medicines by special registration and labeling.

 

US Seeks further Restrictions on Generic Medicines for Developing Countries

have acquired new information indicating that the US seeks further restrictions on exports of generic medicines to developing countries. They fear that the recent talks at the WTO TRIPS Council may result in further threats to access to medicines in poor countries.

 

What Other Programs Can Teach Us: Increasing Participation in Health Insurance Programs

Many uninsured Americans are already eligible for free or low-cost public coverage through Medicaid or Children’s Health Insurance Program (CHIP) but do not "take up" that coverage.

 

 

** In order to view PDF files, you must have Adobe Acrobat Reader installed on your computer. Many computers already have this software; however, if you need it, a free copy is available for download at this site: Click here to get Adobe Acrobat Reader.